Tianjin Xinglian Peptide Biotechnology

ConjuStar focuses on developing next generation innovative oncology therapies.

HQ location

Huangpu, China

Launch date

2022

Employees

Enterprise value

$50—74m

https://www.linkedin.com/company/conjustar/

biotechnology

Authorizing premium user...